,Variant_classification,Gene_classification,Comment,Difficultregion,CNV-SNV,ID,OMIM_Phenotype,Disease,Clinical_synopsis,OMIM_Link,Uniprot,Inheritance,Zygosity,CHR,POS,REF,ALT,Flank,Repeat_flag,FILTER,FORMAT,VAF,Pileup_data,Mutation_type,Gene_name,Entrez_Gene_Id,In_Key_Gene,HGVS_nomenclature,HGMD_transcript,ExonNumber,PolarChange,1000G_ASN_AF,1000G_ALL_AF,ESP6500_AC,ESP6500_AF,gnomAD_exome_ALL,gnomAD_exome_EAS,gnomAD_genome_ALL,gnomAD_genome_EAS,ExAC_EAS_HomoAlt_Count,ExAC_EAS_AC,ExAC_EAS_AF,ExAC_HomoAlt_Count,ExAC_AC,ExAC_AF,In_house_freq,In_house_count,ExAC_Link,ExAC_MisZ,ExAC_Expected,ExAC_observed,ExAC_PLI,PLI_Link,Phylop_Vertebrate_score,Phylop_Mammal_score,SIFT_score,SIFT_prediction,Polyphen2_HDIV_score,Polyphen2_HDIV_pred,Polyphen2_HVAR_score,Polyphen2_HVAR_pred,LRT_score,LRT_prediction,Mutationtatser_score,Mutationtatser_prediction,Gerp++,CADD,Rs_ID,Swiss_prot_function,Swiss_prot_disease_association,Swiss_prot_post_translational_modifications,Swiss_prot_expression,HGMD_mutation_type,HGMD_variant_class,HGMD_disease,HGMD_pubmed_ID,HGMD_indel_type,HGMD_Indel_class,HGMD_indel_disease,HGMD_indel_PMID,HGMD_nearby_alleles,Clinvar,Clinvar_Link,CosmicID,Cosmic_Occurence,Mother_zygosity,Mother_filter,Mother_format,Mother_VAF,Mother_pileup,Father_zygosity,Father_filter,Father_format,Father_VAF,Father_pileup,Recessive,Com_het,De_novo,Other_relatives,Covered,Less_20,GO_BP,GO_CC,GO_MF,KEGG_PATHWAY,PID_PATHWAY,BIOCARTA_PATHWAY,REACTOME_PATHWAY,pheno_rank,intersect_rank,CaseID
4,.,.,OMIM|novel,Name=SegmentalDuplications,.,AX278,300534,"Mental retardation, X-linked, syndromic, Claes-Jensen type","1.$$$mimNumber,300534###prefix,####preferredTitle,MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ###inheritance,X-linked recessive ###growthHeight,Short stature (less than 3rd percentile) ###headAndNeckHead,Microcephaly ;###headAndNeckHead,Macrocephaly ###headAndNeckFace,Small forehead ;###headAndNeckFace,Prognathism ;###headAndNeckFace,Micrognathia ;###headAndNeckFace,Maxillary hypoplasia ;###headAndNeckFace,Facial hypotonia ;###headAndNeckFace,Flat philtrum ###headAndNeckEars,Large ears ;###headAndNeckEars,Raised earlobes ###headAndNeckEyes,Small eyelashes ;###headAndNeckEyes,Small, deep-set eyes ;###headAndNeckEyes,Upslanting palpebral fissures ;###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Hypermetropia ;###headAndNeckEyes,Myopia ###headAndNeckMouth,Thin upper lip ;###headAndNeckMouth,High narrow palate ;###headAndNeckMouth,Scrotal tongue ###headAndNeckTeeth,Diastema ###chestExternalFeatures,Pectus excavatum ###genitourinaryExternalGenitaliaMale,Small penis ;###genitourinaryExternalGenitaliaMale,Small testes ###genitourinaryInternalGenitaliaMale,Cryptorchidism ###skeletalHands,Short distal phalanges ;###skeletalHands,Thick distal phalanges ;###skeletalHands,Brachydactyly ;###skeletalHands,Large hands ###skeletalFeet,Small feet ;###skeletalFeet,Talipes calcaneus ;###skeletalFeet,Club feet ###skinNailsHairHair,Small eyelashes ;###skinNailsHairHair,Abundant body hair ;###skinNailsHairHair,Alopecia areata ###muscleSoftTissue,Lower limb muscle hypotrophy ###neurologicCentralNervousSystem,Mental retardation, severe ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Spastic paraplegia, slowly progressive ;###neurologicCentralNervousSystem,Lower limb hypertonia ;###neurologicCentralNervousSystem,Lower limb hyperreflexia ;###neurologicCentralNervousSystem,Pyramidal syndrome of the lower limbs ;###neurologicCentralNervousSystem,Extensor plantar responses ;###neurologicCentralNervousSystem,Shuffling gait ###neurologicBehavioralPsychiatricManifestations,Aggressive behavior ;###neurologicBehavioralPsychiatricManifestations,Low frustration tolerance ;###neurologicBehavioralPsychiatricManifestations,Restlessness ;###neurologicBehavioralPsychiatricManifestations,Indolence ;###neurologicBehavioralPsychiatricManifestations,Outbursts ;###neurologicBehavioralPsychiatricManifestations,Autistic features (reported in 1 patient) ###miscellaneous,Features in addition to mental retardation are variable ;###miscellaneous,Carrier females may show mild mental retardation or learning disabilities ###molecularBasis,Caused by mutation in the Jumonji, AT-rich interactive domain 1C gene gene (JARID1C, )",https://www.omim.org/entry/300534,.,X-linked recessive,Het,X,53222815,A,C,.,.,PASS,0/1:125:285,43.86,"c$c$,,,Cc.C,..c,,,c.c,,.CC$,,,,.c..Ccc..,,C...,,,c,..c,cCcCC.,.C.,.....,cCC,...c..C,,c...C.c..c,,C,,cc.C.C.CcC.,c..CCc..,...c,cCCC,cc,.ccccC,,.,,cC,C,c,.,.c,c..Cc..Cc,CCcc.,,.cC,,Cc..CC,CC.CccccCCcc..Cc,.cC,C,C,.C....cc,,C.,C.ccCC.cC,,,.C.C,.,..Cc.cC.C,c,,Cccc.,,,C,^]C^]C",missense_variant;missense_variant,KDM5C,8242,.,NM_001146702.1(KDM5C):c.3911T>G(p.Leu1304Arg);NM_004187.3(KDM5C):c.4121T>G(p.Leu1374Arg),NM_004187.3,exon23(24);exon25(26),NP=>P+;NP=>P+,.,.,.,.,5.62e-06,7.781e-05,.,.,.,.,.,.,.,.,.,.,.,5.24,35.3,4,1.0,http://exac.broadinstitute.org/gene/ENSG00000126012,0.13812,.,0.53,T,0.536,P,0.116,B,0.000,D,0.745,D,4.63,7.184,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"histone H3-K4 demethylation (GO:0034720)|negative regulation of transcription, DNA-templated (GO:0045892)|transcription, DNA-templated (GO:0006351)",nucleus (GO:0005634),"DNA binding (GO:0003677)|histone demethylase activity (H3-K4 specific) (GO:0032453)|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors (GO:0016706)|zinc ion binding (GO:0008270)",.,.,.,.,84,5,AX278
18,.,.,OMIM|low_frequency|possible_comhet,.,.,AX278,304800;300539,"Diabetes insipidus, nephrogenic;Nephrogenic syndrome of inappropriate antidiuresis","1.$$$mimNumber,304800###prefix,####preferredTitle,DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED###inheritance,X-linked recessive ###growthHeight,Short stature ###growthOther,Failure to thrive ###abdomenGastrointestinal,Vomiting ;###abdomenGastrointestinal,Constipation ;###abdomenGastrointestinal,Poor feeding ;###abdomenGastrointestinal,Polydipsia ###genitourinaryKidneys,Polyuria ###genitourinaryBladder,Lower urinary tract dilatation may occur over time ###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Mental retardation can occur in patients with repeated episodes of dehydration ###neurologicBehavioralPsychiatricManifestations,Irritability ###metabolicFeatures,Hypertonic dehydration ;###metabolicFeatures,Unexplained fevers ###laboratoryAbnormalities,Hypernatremia ;###laboratoryAbnormalities,Decreased urine osmolality ;###laboratoryAbnormalities,Normal or increased levels of serum arginine vasopressin (antidiuretic hormone, );###laboratoryAbnormalities,Abnormal extrarenal response to dDAVP (no increase in von Willebrand factor or factor VIII) ;###laboratoryAbnormalities,No increase in urinary cyclic AMP (cAMP) in response to vasopressin or dDAVP ###miscellaneous,Onset in first weeks of life ;###miscellaneous,Genetic heterogeneity (see ###molecularBasis,Caused by mutation in the arginine vasopressin receptor-2 gene (AVPR2, ) 2.$$$mimNumber,300539###prefix,####preferredTitle,NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD###inheritance,X-linked recessive ###cardiovascularVascular,Systolic hypertension, mild ###neurologicCentralNervousSystem,Seizures ###neurologicBehavioralPsychiatricManifestations,Irritability ###laboratoryAbnormalities,Hyponatremia ;###laboratoryAbnormalities,Decreased serum osmolality ;###laboratoryAbnormalities,Inappropriately increased urine osmolality ;###laboratoryAbnormalities,Increased urinary sodium ;###laboratoryAbnormalities,Decreased serum BUN ;###laboratoryAbnormalities,Mildly decreased serum creatinine ;###laboratoryAbnormalities,Decreased plasma renin activity ;###laboratoryAbnormalities,Normal aldosterone ;###laboratoryAbnormalities,Euvolemia ;###laboratoryAbnormalities,Undetectable serum arginine vasopressin, or antidiuretic hormone (ADH, AVP, )###miscellaneous,Onset within first 3 months of life ;###miscellaneous,Normal neonatal course ;###miscellaneous,Caused by constitutive activation of the AVPR2 receptor ###molecularBasis,Caused by mutation in the arginine vasopressin receptor 2 gene (AVPR2, )",https://www.omim.org/entry/304800;https://www.omim.org/entry/300539,.,X-linked recessive,Het,X,153171709,G,A,.,.,PASS,0/1:40:76,52.63,".$,aa.,A,aa,,.a,A.a,Aaa,aaaAAA,.a.A.,a.aa,A,aAaa.,aa...,.AaA,,A,,.,A,Aa.",missense_variant;missense_variant,AVPR2,554,.,NM_001146151.1(AVPR2):c.749G>A(p.Gly250Glu);NM_000054.4(AVPR2):c.749G>A(p.Gly250Glu),NM_000054.4,exon2(2);exon2(3),P0=>P-;P0=>P-,0.003,0.0008,0,0,0.0003,0.0041,9.217e-05,0.0019,0,26,0.0039,0,26,0.00030,0.00614754098361,3/488,http://exac.broadinstitute.org/variant/X-153171709-G-A,1.61,5.1,2,0.12,http://exac.broadinstitute.org/gene/ENSG00000126895,0.03041,.,0.99,T,0.001,B,0.005,B,0.003,N,1.000,N,-0.178,0.814,rs34709504,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,activation of adenylate cyclase activity (GO:0007190)|adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188)|excretion (GO:0007588)|hemostasis (GO:0007599)|I-kappaB kinase/NF-kappaB signaling (GO:0007249)|interferon-gamma production (GO:0032609)|negative regulation of renal sodium excretion (GO:0035814)|negative regulation of urine volume (GO:0035811)|positive regulation of cell proliferation (GO:0008284)|positive regulation of gene expression (GO:0010628)|positive regulation of protein ubiquitination (GO:0031398)|positive regulation of systemic arterial blood pressure (GO:0003084)|response to cytokine (GO:0034097)|telencephalon development (GO:0021537)|transmembrane transport (GO:0055085)|water transport (GO:0006833),endoplasmic reticulum (GO:0005783)|endosome (GO:0005768)|Golgi apparatus (GO:0005794)|integral component of membrane (GO:0016021)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886),vasopressin receptor activity (GO:0005000),.,.,.,.,31,1,AX278
19,.,.,OMIM|low_frequency|possible_comhet,.,.,AX278,304800;300539,"Diabetes insipidus, nephrogenic;Nephrogenic syndrome of inappropriate antidiuresis","1.$$$mimNumber,304800###prefix,####preferredTitle,DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED###inheritance,X-linked recessive ###growthHeight,Short stature ###growthOther,Failure to thrive ###abdomenGastrointestinal,Vomiting ;###abdomenGastrointestinal,Constipation ;###abdomenGastrointestinal,Poor feeding ;###abdomenGastrointestinal,Polydipsia ###genitourinaryKidneys,Polyuria ###genitourinaryBladder,Lower urinary tract dilatation may occur over time ###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Mental retardation can occur in patients with repeated episodes of dehydration ###neurologicBehavioralPsychiatricManifestations,Irritability ###metabolicFeatures,Hypertonic dehydration ;###metabolicFeatures,Unexplained fevers ###laboratoryAbnormalities,Hypernatremia ;###laboratoryAbnormalities,Decreased urine osmolality ;###laboratoryAbnormalities,Normal or increased levels of serum arginine vasopressin (antidiuretic hormone, );###laboratoryAbnormalities,Abnormal extrarenal response to dDAVP (no increase in von Willebrand factor or factor VIII) ;###laboratoryAbnormalities,No increase in urinary cyclic AMP (cAMP) in response to vasopressin or dDAVP ###miscellaneous,Onset in first weeks of life ;###miscellaneous,Genetic heterogeneity (see ###molecularBasis,Caused by mutation in the arginine vasopressin receptor-2 gene (AVPR2, ) 2.$$$mimNumber,300539###prefix,####preferredTitle,NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD###inheritance,X-linked recessive ###cardiovascularVascular,Systolic hypertension, mild ###neurologicCentralNervousSystem,Seizures ###neurologicBehavioralPsychiatricManifestations,Irritability ###laboratoryAbnormalities,Hyponatremia ;###laboratoryAbnormalities,Decreased serum osmolality ;###laboratoryAbnormalities,Inappropriately increased urine osmolality ;###laboratoryAbnormalities,Increased urinary sodium ;###laboratoryAbnormalities,Decreased serum BUN ;###laboratoryAbnormalities,Mildly decreased serum creatinine ;###laboratoryAbnormalities,Decreased plasma renin activity ;###laboratoryAbnormalities,Normal aldosterone ;###laboratoryAbnormalities,Euvolemia ;###laboratoryAbnormalities,Undetectable serum arginine vasopressin, or antidiuretic hormone (ADH, AVP, )###miscellaneous,Onset within first 3 months of life ;###miscellaneous,Normal neonatal course ;###miscellaneous,Caused by constitutive activation of the AVPR2 receptor ###molecularBasis,Caused by mutation in the arginine vasopressin receptor 2 gene (AVPR2, )",https://www.omim.org/entry/304800;https://www.omim.org/entry/300539,.,X-linked recessive,Het,X,153171711,C,G,.,.,PASS,0/1:41:76,53.95,",gg.,G,gg,,.g,G.g,Ggg,gggGGGg,.g.G.,g.gg,G,gGgg.,gg...,.GgG,,G,,.G,Gg.^]g",missense_variant;missense_variant,AVPR2,554,.,NM_000054.4(AVPR2):c.751C>G(p.Arg251Gly);NM_001146151.1(AVPR2):c.751C>G(p.Arg251Gly),NM_000054.4,exon2(3);exon2(2),P+=>P0;P+=>P0,0.003,0.0008,0,0,0.0003,0.0041,9.288e-05,0.0019,0,26,0.0039,0,26,0.00030,0.00614754098361,3/488,http://exac.broadinstitute.org/variant/X-153171711-C-G,1.61,5.1,2,0.12,http://exac.broadinstitute.org/gene/ENSG00000126895,0.00820,.,0.56,T,0.143,B,0.109,B,0.004,N,1.000,N,-0.356,0.013,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,activation of adenylate cyclase activity (GO:0007190)|adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188)|excretion (GO:0007588)|hemostasis (GO:0007599)|I-kappaB kinase/NF-kappaB signaling (GO:0007249)|interferon-gamma production (GO:0032609)|negative regulation of renal sodium excretion (GO:0035814)|negative regulation of urine volume (GO:0035811)|positive regulation of cell proliferation (GO:0008284)|positive regulation of gene expression (GO:0010628)|positive regulation of protein ubiquitination (GO:0031398)|positive regulation of systemic arterial blood pressure (GO:0003084)|response to cytokine (GO:0034097)|telencephalon development (GO:0021537)|transmembrane transport (GO:0055085)|water transport (GO:0006833),endoplasmic reticulum (GO:0005783)|endosome (GO:0005768)|Golgi apparatus (GO:0005794)|integral component of membrane (GO:0016021)|integral component of plasma membrane (GO:0005887)|plasma membrane (GO:0005886),vasopressin receptor activity (GO:0005000),.,.,.,.,31,1,AX278
231,.,.,OMIM|low_frequency,"Name=mappability,SegmentalDuplications",.,AX278,613642;256000;252011;614165,"Cardiomyopathy, dilated, 1GG;Leigh syndrome;Mitochondrial respiratory chain complex II deficiency;Paragangliomas 5","1.$$$mimNumber,256000###prefix,####preferredTitle,LEIGH SYNDROME; LS###inheritance,Autosomal recessive ;###inheritance,Mitochondrial ###growthOther,Failure to thrive ###headAndNeckEyes,Ophthalmoplegia ;###headAndNeckEyes,Optic atrophy ;###headAndNeckEyes,Nystagmus ;###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Ptosis ;###headAndNeckEyes,Pigmentary retinopathy ###respiratory,Abnormal respiratory patterns ;###respiratory,Respiratory failure ###skinNailsHairHair,Hypertrichosis ###muscleSoftTissue,Hypotonia ###neurologicCentralNervousSystem,Psychomotor retardation ;###neurologicCentralNervousSystem,Hypotonia ;###neurologicCentralNervousSystem,Ataxia ;###neurologicCentralNervousSystem,Dystonia ;###neurologicCentralNervousSystem,Dysarthria ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Brainstem abnormalities ;###neurologicCentralNervousSystem,Mental retardation ;###neurologicCentralNervousSystem,Lesions in basal ganglia, brainstem, cerebellum, thalamus, spinal cord characterized by demyelination, necrosis, gliosis, spongiosis, and capillary proliferation ###neurologicBehavioralPsychiatricManifestations,Emotional lability ###metabolicFeatures,Lactic acidosis ###laboratoryAbnormalities,Increased serum lactate ;###laboratoryAbnormalities,Increased CSF lactate ###miscellaneous,Onset usually in infancy or early childhood ;###miscellaneous,Progressive disorder, usually with rapid, relentless course ;###miscellaneous,Clinical heterogeneity ;###miscellaneous,Genetic heterogeneity (may be caused by mutation in nuclear-encoded or mitochondrial-encoded genes) ;###miscellaneous,Subset of patients have cytochrome c oxidase deficiency (see );###miscellaneous,See also X-linked Leigh syndrome ();###miscellaneous,See also French-Canadian type of Leigh syndrome ()###molecularBasis,Caused by mutation in the NADH dehydrogenase, subunit 2 gene (MTND2, );###molecularBasis,Caused by mutation in the NADH dehydrogenase, subunit 3 gene (MTND3, );###molecularBasis,Caused by mutation in the NADH dehydrogenase, subunit 5 gene (MTND5, );###molecularBasis,Caused by mutation in the NADH dehydrogenase, subunit 6 gene (MTND6, );###molecularBasis,Caused by mutation in the ATP synthase 6 gene (MTATP6, );###molecularBasis,Caused by mutation in the cytochrome c oxidase III gene (MTCO3, );###molecularBasis,Caused by mutation in the mitochondrial tRNA (valine) gene (MTTV, );###molecularBasis,Caused by mutation in the mitochondrial tRNA (lysine) gene (MTTK, );###molecularBasis,Caused by mutation in the NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 2 gene (NDUFA2, );###molecularBasis,Caused by mutation in the NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 10 gene (NDUFA10, );###molecularBasis,Caused by mutation in the NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 12 gene (NDUFA12, );###molecularBasis,Caused by mutation in the NADH dehydrogenase (ubiquinone) complex I, assembly factor 5 gene (NDUFAF5, );###molecularBasis,Caused by mutation in the NADH dehydrogenase (ubiquinone) Fe-S protein 3 gene (NDUFV3, );###molecularBasis,Caused by mutation in the NADH dehydrogenase (ubiquinone) Fe-S protein 1 gene (NDUFS1, );###molecularBasis,Caused by mutation in the NADH dehydrogenase (ubiquinone) Fe-S protein 4 gene (NDUFS4, );###molecularBasis,Caused by mutation in the NADH dehydrogenase (ubiquinone) Fe-S protein 7 gene (NDUFS7, );###molecularBasis,Caused by mutation in the NADH dehydrogenase (ubiquinone) Fe-S protein 8 gene (NDUFS8, );###molecularBasis,Caused by mutation in the NADH-ubiquinone oxidoreductase 1 alpha subcomplex 9 gene (NDUFA9, );###molecularBasis,Caused by mutation in the succinate dehydrogenase complex, subunit A, flavoprotein gene (SDHA, );###molecularBasis,Caused by mutation in the FAD-dependent oxidoreductase domain-containing protein 1 gene (FOXRED1, );###molecularBasis,Caused by mutation in the bcs1, S. cerevisiae, homolog-like gene (BCS1L, );###molecularBasis,Caused by mutation in the surfeit-1 gene (SURF1, );###molecularBasis,Caused by mutation in the cytochrome c oxidase, subunit 15 gene (COX15, );###molecularBasis,Caused by mutation in the C8ORF38 gene (C8ORF38, );###molecularBasis,Caused by mutation in the translational activator of mitochondrially encoded cytochrome c oxidase subunit 1 gene (TACO1, );###molecularBasis,Caused by mutation in the mitochondrial methionyl-tRNA formyltransferase gene (MTFMT, );###molecularBasis,Caused by mutation in the homolog of the S. cerevisiae PET100 gene (PET100, ). 2.$$$mimNumber,252011###prefix,####preferredTitle,MITOCHONDRIAL COMPLEX II DEFICIENCY###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthOther,Poor growth ###headAndNeckEyes,Ptosis ;###headAndNeckEyes,Ophthalmoplegia ;###headAndNeckEyes,Pigmentary retinopathy ;###headAndNeckEyes,Optic atrophy ;###headAndNeckEyes,Nystagmus ;###headAndNeckEyes,Impaired vision ###cardiovascularHeart,Hypertrophic cardiomyopathy ;###cardiovascularHeart,Dilated cardiomyopathy ;###cardiovascularHeart,Left ventricular noncompaction ###skeletal,Joint contractures ###muscleSoftTissue,Hypotonia, neonatal ;###muscleSoftTissue,Muscle weakness ;###muscleSoftTissue,Exercise intolerance ;###muscleSoftTissue,Ragged red fibers seen on muscle biopsy ;###muscleSoftTissue,Abnormal mitochondria with paracrystalline inclusions seen on muscle biopsy ;###muscleSoftTissue,Accumulated lipid droplets seen on muscle biopsy ###neurologicCentralNervousSystem,Psychomotor regression in infants ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Extensor plantar responses ;###neurologicCentralNervousSystem,Ataxia ;###neurologicCentralNervousSystem,Cognitive impairment ;###neurologicCentralNervousSystem,Dystonia ;###neurologicCentralNervousSystem,Myoclonus ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Leukoencephalopathy, progressive ;###neurologicCentralNervousSystem,Spongiform encephalomyelopathy ;###neurologicCentralNervousSystem,Leigh syndrome (), in a subset of patients;###neurologicCentralNervousSystem,Kearns-Sayre syndrome (), in a subset of patients###metabolicFeatures,Lactic acidosis may occur with stress or infection ###laboratoryAbnormalities,Decreased activity of mitochondrial complex II (succinate dehydrogenase) ;###laboratoryAbnormalities,Mildly increased serum lactate ###miscellaneous,Onset in first year of life ;###miscellaneous,Highly variable phenotype ###molecularBasis,Caused by mutation in the flavoprotein subunit of succinate dehydrogenase complex gene (SDHA, );###molecularBasis,Caused by mutation in the succinate dehydrogenase complex assembly factor 1 gene (SDHAF1, );###molecularBasis,Caused by mutation in the succinate dehydrogenase complex, subunit D, integral membrane protein gene (SDHD, ) 3.$$$mimNumber,614165###prefix,####preferredTitle,PARAGANGLIOMAS 5; PGL5###inheritance,Autosomal dominant ###neoplasia,Paraganglioma ###miscellaneous,Variable locations ###molecularBasis,Caused by mutation in the succinate dehydrogenase complex, subunit A, flavoprotein gene (SDHA, )",https://www.omim.org/entry/613642;https://www.omim.org/entry/256000;https://www.omim.org/entry/252011;https://www.omim.org/entry/614165,.,"Autosomal recessive, Mitochondrial;Autosomal recessive;Autosomal dominant",Het,5,233687,G,A,.,.,PASS,0/1:107:203,52.71,"..A..aA,aaAAaA.a.AA,,.,,AAAA.,,,aa,A,,,,aA.Aa...A.aaA.AA,A,,..A,AaaA.A,aAaa..A.,,...a,,,A.A.AAA,.A.,a,..,aaa,aAAAA,.A.aaAAAA,aaA,.A.,a.a.a,A,AAA.,aaa.A..a..A,AAA.AAA,a,Aa,,aaA,,a.^].^],",missense_variant,SDHA,6389,.,NM_004168.2(SDHA):c.991G>A(p.Ala331Thr),NM_004168.3,exon8(15),NP=>P0,0.004,0.0008,0,0,0.0002,0.0022,0.0002,0.0037,0,15,0.0017,0,17,0.00014,0.00409836065574,2/488,http://exac.broadinstitute.org/variant/5-233687-G-A,2.32,27.7,13,0.0,http://exac.broadinstitute.org/gene/ENSG00000073578,0.89932,.,0,D,1.0,D,0.987,D,0.000,U,1.000,D,4.51,26.7,rs200526913,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,COSM284843,1(large_intestine),.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,cellular metabolic process (GO:0044237)|nervous system development (GO:0007399)|oxidation-reduction process (GO:0055114)|respiratory electron transport chain (GO:0022904)|small molecule metabolic process (GO:0044281)|succinate metabolic process (GO:0006105)|tricarboxylic acid cycle (GO:0006099),mitochondrial inner membrane (GO:0005743)|mitochondrial respiratory chain complex II (GO:0005749)|mitochondrion (GO:0005739),flavin adenine dinucleotide binding (GO:0050660)|succinate dehydrogenase (ubiquinone) activity (GO:0008177),.,.,.,.,12,0,AX278
294,.,.,OMIM|low_frequency|possible_comhet,Name=LowComplexity,.,AX278,608027,"?Pontocerebellar hypoplasia, type 3","1.$$$mimNumber,608027###prefix,####preferredTitle,PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthWeight,Low weight ###headAndNeckHead,Microcephaly ;###headAndNeckHead,Brachycephaly ###headAndNeckFace,Long philtrum ;###headAndNeckFace,Full cheeks ###headAndNeckEars,Low-set ears ;###headAndNeckEars,Large ears ;###headAndNeckEars,Hearing impairment ###headAndNeckEyes,Prominent eyes ;###headAndNeckEyes,Optic atrophy ;###headAndNeckEyes,Wide palpebral fissures ###headAndNeckNose,Depressed nasal bridge ###headAndNeckMouth,High arched palate ;###headAndNeckMouth,Downturned corners of the mouth ###neurologicCentralNervousSystem,Developmental delay, severe ;###neurologicCentralNervousSystem,Neonatal hypotonia ;###neurologicCentralNervousSystem,Poor head control ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Truncal hypotonia ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Small brainstem ;###neurologicCentralNervousSystem,Small cerebellum (especially vermis) ;###neurologicCentralNervousSystem,Cerebral atrophy ;###neurologicCentralNervousSystem,Hypoplasia of the corpus callosum ###miscellaneous,Onset at birth ;###miscellaneous,Progressive disorder ;###miscellaneous,One consanguineous family has been found to carry a homozygous mutation in the PCLO gene (last curated June 2015) ###molecularBasis,Caused by mutation in the homolog of the mouse piccolo gene (PCLO, )",https://www.omim.org/entry/608027,.,Autosomal recessive,Het,7,82763558,-,ATATATATATATATATATATAA,.,Name=227:(TA)n:Simple_repeat,strand fail,0/1:7:21,33.33,"...........+18ATATATATATATATATAA....A.,A..Aa.^]A",splice_region_variant;splice_region_variant,PCLO,27445,.,NM_033026.5(PCLO):c.3300+7_3300+8insTTATATATATATATATATATAT;NM_014510.2(PCLO):c.3300+7_3300+8insTTATATATATATATATATATAT,NM_033026.5,intron3(24);intron3(19),.;.,.,.,0,0,2.023e-05,0.0001,0.0044,0.0377,0,1,0.0030,0,1,0.00010,.,.,http://exac.broadinstitute.org/variant/7-82763558-T-TATATATATATATATATATATAA,-4.32,117.2,11,1.0,http://exac.broadinstitute.org/gene/ENSG00000186472,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,82,4,AX278
295,.,.,OMIM|novel|lowVAF|possible_comhet,Name=GCcontent,.,AX278,608027,"?Pontocerebellar hypoplasia, type 3","1.$$$mimNumber,608027###prefix,####preferredTitle,PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthWeight,Low weight ###headAndNeckHead,Microcephaly ;###headAndNeckHead,Brachycephaly ###headAndNeckFace,Long philtrum ;###headAndNeckFace,Full cheeks ###headAndNeckEars,Low-set ears ;###headAndNeckEars,Large ears ;###headAndNeckEars,Hearing impairment ###headAndNeckEyes,Prominent eyes ;###headAndNeckEyes,Optic atrophy ;###headAndNeckEyes,Wide palpebral fissures ###headAndNeckNose,Depressed nasal bridge ###headAndNeckMouth,High arched palate ;###headAndNeckMouth,Downturned corners of the mouth ###neurologicCentralNervousSystem,Developmental delay, severe ;###neurologicCentralNervousSystem,Neonatal hypotonia ;###neurologicCentralNervousSystem,Poor head control ;###neurologicCentralNervousSystem,Seizures ;###neurologicCentralNervousSystem,Hyperreflexia ;###neurologicCentralNervousSystem,Truncal hypotonia ;###neurologicCentralNervousSystem,Spasticity ;###neurologicCentralNervousSystem,Small brainstem ;###neurologicCentralNervousSystem,Small cerebellum (especially vermis) ;###neurologicCentralNervousSystem,Cerebral atrophy ;###neurologicCentralNervousSystem,Hypoplasia of the corpus callosum ###miscellaneous,Onset at birth ;###miscellaneous,Progressive disorder ;###miscellaneous,One consanguineous family has been found to carry a homozygous mutation in the PCLO gene (last curated June 2015) ###molecularBasis,Caused by mutation in the homolog of the mouse piccolo gene (PCLO, )",https://www.omim.org/entry/608027,.,Autosomal recessive,Het,7,82785712,G,T,.,.,strand fail|low coverage,0/1:3:17,17.65,",$,,.,,,..T,.,,",splice_region_variant;splice_region_variant,PCLO,27445,.,NM_033026.5(PCLO):c.249-4C>A;NM_014510.2(PCLO):c.249-4C>A,NM_033026.5,intron1(24);intron1(19),.;.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,-4.32,117.2,11,1.0,http://exac.broadinstitute.org/gene/ENSG00000186472,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,82,4,AX278
327,.,.,OMIM|low_frequency,.,.,AX278,615541,"Mental retardation, autosomal recessive 39","1.$$$mimNumber,615541###prefix,####preferredTitle,MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39###inheritance,Autosomal recessive ###growthHeight,Short stature ###headAndNeckHead,Microcephaly (-3 to -4 SD) ###headAndNeckFace,Sloping forehead ###headAndNeckEars,Anteverted ears ;###headAndNeckEars,Large ears ###headAndNeckEyes,Deep-set eyes ;###headAndNeckEyes,Strabismus ;###headAndNeckEyes,Synophrys ###headAndNeckNose,Prominent nose ###headAndNeckTeeth,Malposition of the teeth ###skeletalSpine,Kyphoscoliosis ###neurologicCentralNervousSystem,Delayed psychomotor development ;###neurologicCentralNervousSystem,Mental retardation, moderate to severe ;###neurologicCentralNervousSystem,Speech delay, severe ###neurologicBehavioralPsychiatricManifestations,Hyperactivity ;###neurologicBehavioralPsychiatricManifestations,Aggression ;###neurologicBehavioralPsychiatricManifestations,Stereotyped behavior ###immunology,Decreased circulating naive T cells (1 family) ###miscellaneous,Onset in infancy ;###miscellaneous,Dysmorphic facial features reported in 1 family ;###miscellaneous,Two unrelated families have been reported (last curated November 2013) ###molecularBasis,Caused by mutation in the TELO2-interacting protein 2 gene (TTI2, )",https://www.omim.org/entry/615541,.,Autosomal recessive,Het,8,33369806,G,A,.,.,PASS,0/1:54:103,52.43,",$aA.,a,A..a,A,.a.AAaaA,.,AaAa..,a,a.a,,,AA,,aaA..,A..,.A.AAa,a,AA.AA.aAAA,aA.Aaaa.aaaA,A..A..AA.,...",missense_variant;missense_variant;missense_variant,TTI2,80185,.,NM_001102401.2(TTI2):c.326C>T(p.Ala109Val);NM_001265581.1(TTI2):c.326C>T(p.Ala109Val);NM_025115.3(TTI2):c.326C>T(p.Ala109Val),NM_001102401.2,exon2(8);exon2(8);exon1(7),NP=>NP;NP=>NP;NP=>NP,.,.,1,0.000077,7.31e-05,0.0010,3.229e-05,0.0006,0,11,0.0013,0,12,0.000099,.,.,http://exac.broadinstitute.org/variant/8-33369806-G-A,-0.18,15.4,7,0.0,http://exac.broadinstitute.org/gene/ENSG00000129696,0.02453,0.0,1,T,0.0,B,0.0,B,0.066,N,0.997,N,1.77,0.434,rs144105577,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,65,3,AX278
497,.,.,HGMD|OMIM|possible_comhet,.,.,AX278,114480;612555;605724;613029;155255;613347;176807;194070,"Breast cancer, male, susceptibility to;Breast-ovarian cancer, familial, 2;Fanconi anemia, complementation group D1;Glioblastoma 3;Medulloblastoma;Pancreatic cancer 2;Prostate cancer;Wilms tumor","1.$$$mimNumber,114480###prefix,####preferredTitle,BREAST CANCER###inheritance,Autosomal dominant ###neoplasia,Breast carcinoma ###miscellaneous,Genetic heterogeneity ###molecularBasis,Caused by mutation in the breast cancer type 1 gene (BRCA1, );###molecularBasis,Caused by mutation in the breast cancer type 2 gene (BRCA2, );###molecularBasis,Caused by mutation in the solute carrier family 22, member 1-like gene (SLC22A1L, );###molecularBasis,Caused by mutation in the tumor protein p53 gene (TP53, );###molecularBasis,Caused by mutation in the BRCA1-associated C-terminal helicase 1 gene (BRIP1, );###molecularBasis,Caused by mutation in the homolog of the S. cerevisiae RAD51A gene (RAD51A, );###molecularBasis,Susceptibility conferred by mutation in the homolog of the S. pombe checkpoint kinase 2 gene (CHEK2, ) 2.$$$mimNumber,612555###prefix,####preferredTitle,BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2###inheritance,Autosomal dominant ###neoplasia,Breast cancer ;###neoplasia,Ovarian cancer ###miscellaneous,Mutation carriers have an increased risk of developing breast and/or ovarian cancer at an earlier age ;###miscellaneous,Lifetime risk of breast cancer in mutation carriers is 60 to 85% ;###miscellaneous,Lifetime risk of ovarian cancer in mutation carriers is 10 to 20% ;###miscellaneous,Lifetime risk of breast cancer in male mutation carriers in 6% ;###miscellaneous,Increased risk of bilateral breast cancer ###molecularBasis,Susceptibility conferred by mutation in the breast cancer 2 gene (BRCA2, ) 3.$$$mimNumber,605724###prefix,####preferredTitle,FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1###inheritance,Autosomal recessive ###growthHeight,Short stature ###growthOther,Intrauterine growth retardation ;###growthOther,Failure to thrive ###headAndNeckHead,Microcephaly ###headAndNeckFace,Dysmorphic facial features, nonspecific (in some patients) ###cardiovascularHeart,Cardiac defects (in some patients) ###abdomenGastrointestinal,Imperforate anus ###skeletalHands,Hypoplastic thumbs ;###skeletalHands,Abnormal thumbs ###skinNailsHairSkin,Cafe au lait spots ###hematology,Bone marrow failure ###neoplasia,Increased susceptibility to leukemia ;###neoplasia,Increased susceptibility to solid cancers ###laboratoryAbnormalities,Multiple chromosomal breaks ;###laboratoryAbnormalities,Chromosomal breakage induced by diepoxybutane (DEB), and mitomycin C ###miscellaneous,Onset in infancy or early childhood ;###miscellaneous,Extreme sensitivity to chemotherapy ###molecularBasis,Caused by mutation in the BRCA2 gene (BRCA2, ) 4.$$$mimNumber,613029###prefix,####preferredTitle,GLIOMA SUSCEPTIBILITY 3; GLM3###inheritance,Autosomal recessive ###neoplasia,Brain tumors, multiple types ;###neoplasia,Glioblastoma ;###neoplasia,Medulloblastoma ;###neoplasia,Astrocytoma ###molecularBasis,Susceptibility conferred by mutation in the BRCA2 gene (BRCA2, ) 5.$$$mimNumber,155255###prefix,####preferredTitle,MEDULLOBLASTOMA; MDB###inheritance,Somatic ;###inheritance,Autosomal dominant ;###inheritance,Autosomal recessive ###neoplasia,Medulloblastoma ###laboratoryAbnormalities,Isochromosome 17q frequent in cytogenetic studies;###laboratoryAbnormalities,Loss of heterozygosity for 17p sequences in 45% of medulloblastomas###miscellaneous,Incomplete penetrance ###molecularBasis,Caused by mutation in the suppressor of fused gene (SUFU, );###molecularBasis,Caused by mutation in the BRCA2 gene (BRCA2, );###molecularBasis,Caused by somatic mutation in the catenin beta 1 gene (CTNNB1, );###molecularBasis,Caused by somatic mutation in the homolog of Drosophila patched 2 gene (PTCH2, ) 6.$$$mimNumber,194070###prefix,####preferredTitle,WILMS TUMOR 1; WT1###inheritance,Autosomal dominant ;###inheritance,Somatic mutation ###genitourinaryKidneys,Nephroblastoma ###neoplasia,Nephroblastoma ###miscellaneous,Majority of Wilms tumors are sporadic ;###miscellaneous,Onset between 2-5 years ;###miscellaneous,Rare adult cases reported ;###miscellaneous,5-10% of all Wilms tumor are bilateral ;###miscellaneous,21% of hereditary Wilms tumor are bilateral ;###miscellaneous,Associated with several congenital malformation syndromes (WAGR , abnormal urogenital development syndromes);###miscellaneous,Two-step mutation hypothesis (germline mutation followed by somatic mutation or two sequential somatic mutations) ;###miscellaneous,Loss of tumor suppressor gene ;###miscellaneous,Genetic heterogeneity ;###miscellaneous,Associated with several loci on chromosomes 11p15 (WT2, ).###molecularBasis,Caused by mutation in the WT1 gene (WT1, );###molecularBasis,Caused by mutation in the BRCA2 gene (BRCA2, )",https://www.omim.org/entry/114480;https://www.omim.org/entry/612555;https://www.omim.org/entry/605724;https://www.omim.org/entry/613029;https://www.omim.org/entry/155255;https://www.omim.org/entry/613347;https://www.omim.org/entry/176807;https://www.omim.org/entry/194070,.,"Autosomal dominant;Autosomal recessive;Autosomal recessive, Autosomal dominant;Autosomal dominant, Somatic mutation",Het,13,32906977,A,G,.,.,PASS,0/1:32:73,43.84,",,,gg....Gg,GG,gGgg,,g,G..g,.GgGG,.g,g..,.Ggg.,,..,g.Gg...GGgG..G,.,^],",synonymous_variant,BRCA2,675,.,NM_000059.3(BRCA2):c.1362A>G(p.Lys454=),NM_000059.3,exon10(27),.,0.0069,0.0014,0,0,0.0004,0.0050,0.0002,0.0031,1,36,0.0042,1,36,0.00030,0.00409836065574,2/488,http://exac.broadinstitute.org/variant/13-32906977-A-G,-4.71,69.8,36,0.0,http://exac.broadinstitute.org/gene/ENSG00000139618,.,.,.,.,.,.,.,.,.,.,.,.,.,.,rs55919657,.,.,.,.,.,.,.,.,.,.,.,.,"NM_000059.3(BRCA2):c.1362delA,DM,Breast cancer,22034289",51108,https://www.ncbi.nlm.nih.gov/clinvar/variation/51108,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,"brain development (GO:0007420)|cell aging (GO:0007569)|centrosome duplication (GO:0051298)|cytokinesis (GO:0000910)|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)|DNA repair (GO:0006281)|double-strand break repair (GO:0006302)|double-strand break repair via homologous recombination (GO:0000724)|female gonad development (GO:0008585)|hemopoiesis (GO:0030097)|histone H3 acetylation (GO:0043966)|histone H4 acetylation (GO:0043967)|inner cell mass cell proliferation (GO:0001833)|intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)|male meiosis I (GO:0007141)|negative regulation of mammary gland epithelial cell proliferation (GO:0033600)|nucleotide-excision repair (GO:0006289)|oocyte maturation (GO:0001556)|positive regulation of mitotic cell cycle (GO:0045931)|positive regulation of transcription, DNA-templated (GO:0045893)|regulation of cytokinesis (GO:0032465)|replication fork protection (GO:0048478)|response to gamma radiation (GO:0010332)|response to UV-C (GO:0010225)|response to X-ray (GO:0010165)|spermatogenesis (GO:0007283)",BRCA2-MAGE-D1 complex (GO:0033593)|centrosome (GO:0005813)|cytoplasm (GO:0005737)|nucleoplasm (GO:0005654)|nucleus (GO:0005634)|protein complex (GO:0043234)|secretory granule (GO:0030141),gamma-tubulin binding (GO:0043015)|H3 histone acetyltransferase activity (GO:0010484)|H4 histone acetyltransferase activity (GO:0010485)|protease binding (GO:0002020)|single-stranded DNA binding (GO:0003697),.,.,.,.,88,6,AX278
498,.,.,novel|possible_comhet,.,.,AX278,.,.,.,.,.,.,Het,13,32972761,A,G,.,.,PASS,0/1:45:84,53.57,",GG.gG..,G.G,.g,.,..ggG...G,..gG.GGGGG.GGG.gggGGG...,,.gGGg,.GgGGG,..G.,.g,g..GGG.^]g",missense_variant,BRCA2,90634,.,NM_000059.3(BRCA2):c.10111A>G(p.Thr3371Ala),NM_000059.3,exon27(27),P0=>NP,.,.,.,.,4.064e-06,5.798e-05,3.228e-05,0.0006,.,.,.,.,.,.,.,.,.,-4.71,69.8,36,0.0,http://exac.broadinstitute.org/gene/ENSG00000139618,0.53079,.,0.36,T,0.214,B,0.031,B,0.014,N,1.000,N,4.54,15.81,rs80358393,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,88,6,AX278
511,.,.,truncating|low_frequency,.,.,AX278,.,.,.,.,.,.,Het,14,24709067,G,-,.,.,PASS,0/1:51:95,53.68,",$.,-1g.-1G.-1G..-1G..-1G.-1G,-1g,.-1G,-1g.-1G.-1G,-1g.-1G.-1G.,,,-1g.-1G.-1G,-1g.-1G.,.,-1g,-1g,.,,.-1G.-1G,-1g.,-1g,..,-1g.-1G,-1g,-1g.-1G.-1G,,-1g.-1G..-1G,,-1g.-1G.-1G.-1G..,-1g.-1G....-1G,.,.,.,-1g.,-1g.-1G,....-1G,-1g,-1g.,.,.-1G..-1G.-1G.,",frameshift_variant,TINF2,51292,.,NM_001099274.1(TINF2):c.1292delC(p.Pro431LeufsTer31),NM_001099274.1,exon9(9),.,.,.,0,0,2.843e-05,0.0004,3.232e-05,0.0006,0,2,0.00023,0,2,0.000017,.,.,http://exac.broadinstitute.org/variant/14-24709066-AG-A,1.25,18.9,5,0.16,http://exac.broadinstitute.org/gene/ENSG00000092330,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,GMP metabolic process (GO:0046037)|nucleobase-containing small molecule metabolic process (GO:0055086)|purine nucleobase metabolic process (GO:0006144)|purine-containing compound salvage (GO:0043101)|small molecule metabolic process (GO:0044281),cytosol (GO:0005829)|GMP reductase complex (GO:1902560),GMP reductase activity (GO:0003920)|metal ion binding (GO:0046872),.,.,.,.,32,2,AX278
